MSOS 4.74 ▲ 0.21% - Fund Analysis & Holdings - Stocknear

AdvisorShares Pure US Can...

AMEX: MSOS · Real-Time Price · USD
4.74
0.01 (0.21%)
At close: Sep 08, 2025, 3:59 PM
4.77
0.74%
After-hours: Sep 08, 2025, 07:59 PM EDT
0.21%
Bid 4.72
Market Cap 342.73M
AUM 845.55M
NAV 4.78
EPS (ttm) n/a
PE Ratio (ttm) n/a
Shares Out 72.38M
Inception Date Sep 1, 2020
Ask 4.93
Volume 5.07M
Open 4.78
Previous Close 4.73
Day's Range 4.72 - 4.88
52-Week Range 2.02 - 7.92
Holdings 28
Expense Ratio 0.79%

About MSOS

The First U.S.-Listed ETF Available – MSOS is the first actively managed U.S.-listed ETF with dedicated cannabis exposure focusing exclusively on U.S. companies, including multi-state operators. The portfolio manager allocates across an investable universe of U.S. companies spanning a variety of cannabis-related businesses. Easy Access to U.S. Cannabis Exposure – MSOS trades on the NYSE Arca exchange, offering exposure to multiple cannabis securities in a convenient, single trade. To buy U.S. cannabis companies on your own, investors will need to seek these stocks out in smaller, foreign exchanges. Experience – MSOS’ portfolio manager has deep experience in the capital markets and well-established expertise investing in highly-regulated areas in the equity markets, including cannabis. MSOS assets are held by one of the largest U.S. custodial banks, BNY Mellon.

Asset Class Equity
Ticker Symbol MSOS
Inception Date Sep 1, 2020
Provider Advisorshares
Exchange AMEX

Top Sectors

Sector Weight %
View All Sectors

Top 10 Holdings 8.63% of assets

Name Symbol Weight
Green Thumb Industri... GTBIF 8.02%
Village Farms Intern... VFF 0.38%
Sndl Inc. SNDL 0.23%
View More Holdings

Dividends Dividend Yield 0.28%

Ex-Dividend Amount Payment Date
Dec 23, 2021 $0.0700 Dec 31, 2021
Full Dividend History
2 weeks ago
+5.2%
Shares of cannabis stocks are trading higher amid ... Unlock content with Pro Subscription
4 weeks ago
+25.67%
Shares of cannabis-related stocks are trading higher following a report suggesting President Trump is considering rescheduling marijuana as a Schedule III drug that would reclassify it as a less dangerous and ease restrictions.